The protein expression market was valued at USD 1,654.0 million in 2017 and is expected to grow at a CAGR of 11.5% to a USD 2,850.5 million market by 2022. Factors driving this market are the increasing prevalence of chronic disorders, technological advancements in the field of protein expression systems, and increasing funding for protein-based research. On the other hand, rising market consolidation and the high cost of protein expression reagents and instruments are restraining the growth of this market.
Mammalian cell expression systems segment is expected to register the highest CAGR during the forecast period
The protein expression market is classified into insect cell expression systems; mammalian cell expression systems; prokaryotic expression systems, yeast expression systems; cell-free expression systems; and algal-based expression systems, on the basis of systems type. The mammalian cell expression system segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the high adoption of these systems in the protein based reasech and therapeutic protein manufacturing as they have the capacity for post-translational modification and human protein-like molecular structure assembly.
Reagents segment is expected to register the highest CAGR during the forecast period
The protein expression market is classified by products, into competent cells, expression vectors, instruments, reagents, and services. The reagents segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the increase in protein expression research activities and the large-scale production of antibodies and vaccines.
Increasing prevalence of chronic disorders to drive growth of the therapeutic applications segment
Based on application, the global protein expression market is segmented into therapeutic applications, industrial applications, and research applications. The therapeutic application segment is expected to register highest CAGR during the forecast period. The growth in this segment is primarily attributed to increasing incidences of chronic disorders and the rising demand for therapeutic proteins.
The CROs end-user segment is expected to register high growth during the forecast period
The protein expression market is classified on the basis of end users into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry). The CROs segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the increase in outsourcing of pharmaceutical manufacturing/clinical trial processes.
North America is account for the largest regional segment in the market
Geographically, the protein expression systems market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and this trend is expected to continue during the forecast period. Growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and rising prevalence of chronic diseases.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1 – 25 %, Tier 2 – 35% and Tier 3 – 40%
- By Designation – C level – 35%, Director level – 25%, Others – 40%
- By Region – North America - 43%, Europe – 19%, APAC – 29%, RoW – 9%
Key players operating in the protein expression market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), GenScript Biotech Corporation (China), Agilent Technologies Inc. (U.S.), Takara Bio, Inc. (Japan), Promega Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.) , QIAGEN N.V. (The Netherlands) , Lonza Group Ltd.(Switzerland), and New England Biolabs Inc.(U.S.)
This report analyses the protein expression market by systems type, systems type, products, applications, end users, and regions. Apart from offering a comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. The report also profiles companies with product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions to be successful in the market.
Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.
The report provides insights on the following strategies:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the protein expression market. The report analyzes the protein expression market by systems type, product, application and end user
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the protein expression market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various protein expression products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the protein expression market